In only six months, Kael Draven had turned whispers into dominance. When he and Astra had first stepped foot in Europe, their name was little more than a rumor carried by Mukul's growing alliance. Now, the name Draven was carved into the very foundations of Europe's medical empire.
The headquarters in Geneva gleamed like a fortress of glass and steel, overlooking the lake. Within its walls, labs operated day and night—developing treatments, biogenetic breakthroughs, and life-saving pharmaceuticals. Kael's vision was not limited to medicine as it was known; he sought to merge healing with innovation, crafting a model where science, internal energy mastery, and technology worked as one.
By the third month, Draven Biotech had already acquired two mid-tier pharmaceutical companies in Switzerland and France. By the fourth, Kael had absorbed a German medical research institute that specialized in bioengineering. Each acquisition was not just about expansion—it was about weaving a network of influence. He placed loyalists in charge, those who believed in the Draven vision, those who would stand firm when rivals attempted to undermine them.
By the sixth month, the results were undeniable.
— Draven Biotech ranked in the Top 5 pharmaceutical enterprises in Europe, rivaling giants that had dominated for decades.— Their research division announced the release of an advanced regenerative serum, cutting recovery times from major surgeries by nearly 40%.— Their humanitarian wing supplied free vaccines and medical aid across Eastern Europe, winning not only markets but also hearts.— Kael himself had been invited to multiple panels of the European Medical Council, his name now spoken alongside leaders who once dismissed him as an outsider.
Yet behind the gleaming success, Kael never forgot the greater purpose. At night, when the boardroom emptied, he often stood alone by the tall windows, watching the city lights. This isn't only for empire, he thought. This is for them—for Mukul, for Astra, for the Ahir name that must rise again.
It was during one of these nights that Astra joined him, her quiet presence filling the room. She leaned against him, her voice soft but steady. "Six months, and you've conquered what others could not in decades."
Kael smiled faintly, though his eyes carried the weight of responsibility. "Conquered is too strong a word. I've only built a foundation. The real war has not even begun."
"And yet," Astra countered, "you've already carved a place for the Dravens. You've given our children a name they can stand proud of."
At that, Kael's hand tightened around hers. For him, this was more than empire—it was legacy, protection, and the hope that his children would grow in a world where they were not hunted, but respected.
Still, shadows lingered on the horizon. Rivals in the pharmaceutical world had begun whispering about Draven's meteoric rise, and political lobbies were already sharpening their knives. Kael knew every victory drew attention—not just from competitors, but from enemies that moved in darker alleys.
He turned from the window, his decision clear. "It's time we fortify. We've won the first battle, Astra. Now, we prepare for the storm."
Six months had made Kael Draven a titan of Europe's medical stage. But deep inside, he understood—this was only the beginning.